Literature DB >> 9360247

Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study.

K Fukuizumi1, M Sata, H Suzuki, H Nakano, K Tanikawa.   

Abstract

We have studied the prevalence, seroconversion rate of anti-hepatitis C virus (HCV), and the transmission of HCV in a cohort of individuals living in a hyperendemic area of HCV in Japan. We investigated 509 subjects, of which 375 could be studied again after 5 years. A remarkable high prevalence of anti-HCV (23.4-24.0%) was observed. Of 287 subjects negative at the first examination in 1990, 4 became positive until the second in 1995 (seroconversion rate: 0.28% per year). Furthermore, we investigated the route of transmission in HCV seroconverted subjects through a detailed interview. All of the HCV seroconverted subjects had past histories of medical treatment. Seroconversion rates of HCV in a hyperendemic area of HCV, were extremely high. Medical treatment was considered to be a causative route of HCV transmission.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360247     DOI: 10.3109/00365549709011828

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

Review 1.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

2.  Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan.

Authors:  Yumiko Nagao; Michio Sata
Journal:  Virol J       Date:  2010-12-31       Impact factor: 4.099

3.  A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus.

Authors:  Yumiko Nagao; Michio Sata
Journal:  BMC Gastroenterol       Date:  2012-04-10       Impact factor: 3.067

4.  Increasing newly diagnosed rate and changing risk factors of HCV in Yanbian Prefecture, a high endemic area in China.

Authors:  Hong-Xin Piao; Ai-Ting Yang; Ya-Meng Sun; Yuan-Yuan Kong; Xiao-Ning Wu; Ying-Zhe Zhang; Bo Ding; Bao-En Wang; Ji-Dong Jia; Hong You
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.